Introduction – Company Background
GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.
With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.
With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.
From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.
At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.
By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.
Core Strengths in Insole Manufacturing
At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.
Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.
We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.
With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.
Customization & OEM/ODM Flexibility
GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.
Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.
With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.
Quality Assurance & Certifications
Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.
We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.
Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.
ESG-Oriented Sustainable Production
At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.
To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.
We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.
Let’s Build Your Next Insole Success Together
Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.
From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.
Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.
🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw
Pillow OEM for wellness brands Taiwan
Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.
With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Graphene cushion OEM production factory in Taiwan
Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.
We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Orthopedic pillow OEM solutions Thailand
At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Taiwan pillow OEM manufacturing factory
📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Customized sports insole ODM Taiwan
Researchers have applied a technique called fluorescence in situ hybridization (FISH) to analyze sperm DNA for various chromosomal defects simultaneously. A new test quickly and easily identifies when sperm are carrying chromosomal mutations, and could be applied for men hoping to have children. Chemotherapy and radiation treatments are known to cause harsh side effects that patients can see or feel throughout their bodies. Yet there are additional, unseen and often undiscussed consequences of these important therapies: the impacts on their future pregnancies and hopes for healthy children. Extensive evidence shows that chemotherapy and radiation treatments are genotoxic, meaning they can mutate the DNA and damage chromosomes in patients’ cancerous and noncancerous cells alike. When this occurs in a germline cell – which are egg cells in women and sperm in men – it can lead to serious fetal and birth defects in a resulting pregnancy. For the few chemotherapies that have been studied, the risk of mutated sperm diminishes over time, as the treatment agents leave the body and men produce new sperm that were never exposed to the genotoxic agents. But for most chemotherapeutic drugs, there is still no information on their impact on DNA mutations and chromosomal damage to human sperm. Human sperm stained for semen quality testing in the clinical laboratory. Credit: Bobjgalindo/Wikimedia Exacerbating the problem, there are currently no efficient and affordable tests that can be used to track men’s germ cell health by identifying when the sperm are carrying treatment-related chromosomal mutations such as aneuploidy (abnormal number of chromosomes) or chromosome breaks, rearrangements, or deletions. But evidence from a new study led by Andrew Wyrobek at the Lawrence Livermore National Laboratory, and now at the Lawrence Berkeley National Laboratory (Berkeley Lab), suggests that this may soon change. AM8 Sperm FISH Protocol In a paper published in the journal PLOS One, the international team reported success adapting an established cellular DNA analysis technique called fluorescence in situ hybridization (FISH) to probe sperm DNA for a wide variety of chromosomal defects simultaneously. This version of the FISH technique, known as the AM8 sperm FISH protocol, is the result of decades of work done by the research team of lead author Andrew Wyrobek. A medical biophysicist at Berkeley Lab, Wyrobek studies the effects of ionizing radiation and human-made chemicals on breast cancer, brain function, and male reproductive health. “This work is the first demonstration that our sperm assay can simultaneously measure aneuploidy and other chromosomal aberrations in sperm from men who have undergone genotoxic treatments,” said Wyrobek. “When sperm with these chromosomal abnormalities fertilize an egg, the resulting fetus and live-born child may have severe health issues. For example, fetuses with trisomy 18 – an extra copy of chromosome 18 or a fetus with an unbalanced chromosomal rearrangement – typically die in utero or within a year of birth.” And, most importantly, according to Wyrobek, the assay can detect balanced chromosomal abnormalities, which are rearrangement with no loss or gain of genetic material. Balanced rearrangements are compatible with live birth and heritable to future pregnancies, and affected children are likely to experience reduced fertility when they want to have children of their own. The team – which included scientists from Lawrence Livermore National Laboratory, Stanford University, MD Anderson Cancer Center, and the National Autonomous University of Mexico – evaluated the AM8 FISH approach on sperm from nine Hodgkin lymphoma patients, who provided samples before, during, and after a multi-drug treatment regimen and radiation therapy. Encouraging Signs of Sperm Recovery Post-Treatment Results from the FISH protocol tests indicated that sperm produced during the Hodgkin lymphoma treatment had 10 times more chromosomal defects compared with sperm produced prior to treatment. But by month six post-treatment, the patients’ sperm had returned to pre-treatment quality. “We are excited by these results because they are a first step toward applying this method to any human situation – such as aging, illness, drugs, or exposure to environmental toxicants – to determine genetic risks to male germ cells and to examine the persistence of chromosomally damaged sperm,” said Wyrobek. “We believe this approach has a wide range of applications in healthcare and family planning, as it can be used to identify environmental exposures that increase the risk for producing chromosomally abnormal sperm that can affect the health of future pregnancies and children for generations to come.” However, according to Wryobek, the sperm FISH method is still in an early research phase and it will require additional validation and commercial development before it becomes available in doctor’s offices. Reference: “Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma” by Sara Frias, Paul Van Hummelen, Marvin L. Meistrich and Andrew J. Wyrobek, 28 December 2020, PLOS ONE. DOI: 10.1371/journal.pone.0242218 This work was supported by the National Institute of Environmental Health Science and the authors’ respective institutions.
Scientists propose that ancient human reproductive behavior and the female menstrual cycle were aligned with the moon but have been largely disrupted by modern lifestyles and artificial light. Women’s menstrual cycles sometimes align with lunar cycles, likely influenced by moonlight and gravity. The blog “Ladyplanet. Natürlich Frau sein” is quite certain: “Our cycle is linked to that of the moon. The most obvious connection is the length of the two cycles,” it says. The newspaper “Berliner Tagesspiegel” comes to the opposite conclusion: “The length of women’s menstrual cycles is an average value, for some it lasts longer, for others it is shorter. Even the same woman can have cycles of different lengths. If they really were connected to the lunar cycle, all women would have their fertile days at the same time,” the paper’s knowledge section reads. So what is true? A team led by Würzburg chronobiologist Charlotte Förster has now used scientific methods to examine the connection between lunar and women’s menstrual cycles. The result: The scientists hypothesize that in ancient times human reproductive behavior and the female menstrual cycle were synchronous with the moon but that our modern lifestyles and artificial light have largely changed this synchrony. Förster holds the Chair of Neurobiology and Genetics at the University of Würzburg (JMU). The results of her study have now been published online in the journal Science Advances. Correlation Between Moon Phases, Pregnancy and Birth Rate “We know many animal species in which the reproductive behavior is synchronized with the lunar cycle to increase reproductive success,” says Charlotte Förster. Since the menstrual cycle of women is similar in length to the lunar cycle with its approximately 29.5 days, a connection seems likely. This is also supported by a number of other findings: For example, several older studies show that women whose cycles are in sync with that of the moon have the highest probability of becoming pregnant. Two large longitudinal studies demonstrate a significant correlation between birth rate and lunar phase with a slight increase in birth rate at full moon and a corresponding decrease at new moon. Recent evidence also suggests that births are more likely to occur at night during a full moon and during the day when there is a new moon. To clarify the influence of the moon on human reproduction, Förster and her colleagues from Munich, Buenos Aires, and the USA studied the course of the menstrual cycles of 22 women who had kept menstrual diaries — in some cases over a period of 32 years. “To our knowledge, this approach to analyzing this type of long-term data has not been used before,” Förster says. Instead, previous studies had analyzed large numbers of women in their entirety, combining results from different women, age groups, years, and seasons. The Moon Orbits Earth in Several Cycles The team correlated the records of each of the 22 women with the lunar cycle. Whereas “lunar cycle” is actually an unacceptable simplification. “Scientifically speaking, the moon exhibits three distinct cycles that periodically change its luminance and the gravity with which it impacts Earth,” Förster says. On the one hand, there is the change between full moon and new moon which takes place on average every 29.53 days with slight variations. Secondly, the moon does not go around Earth in a fixed orbit. Instead, its position varies relative to the equator. Sometimes it is more to the north, sometimes more to the south. This cycle lasts 27.32 days. The third cycle is a little longer with an average of 27.55 days. It results from the fact that the moon accompanies Earth on an elliptical orbit and is accordingly sometimes closer, sometimes further away. All of these cycles affect the intensity of the moonlight and gravity, which can be seen in the tides, for example. In addition, they interact with each other and can lead to special constellations at longer intervals, producing special phenomena, such as a solar eclipse, which is part of a regular cycle where the darkening of the sun repeats about every 18 years. Moonlight Is the Strongest Clock Generator “All three lunar cycles influence the onset of menstruation in women”: This is the conclusion the scientists draw after evaluating the records of the study participants. The nightly moonlight seems to be the strongest clock synchronizer, but the gravitational forces of the moon also contribute to the effect. Of course: Not all women follow the change of light and dark in the night sky and if they do, usually only for certain periods of time. On average, in women under 35 years of age, menstruation occurs synchronously with the full moon or new moon in just under a quarter of the recorded time. For women over 35, this is the case on average in barely one tenth of the time. The synchronism of lunar and menstrual cycle does not only decrease with increasing age: It also seems to decrease to the extent that women are exposed to artificial light sources at night. Typical “night owls,” who go to bed late and leave the lights on longer, show no obvious synchronization with the moon. A Sense of Gravity According to the scientists, the fact that synchronization occurs only sporadically and that the courses of women’s menstrual cycles vary suggests that the moon’s light-dark cycle alone is not a strong synchronizing factor of menstruation. They have the first evidence that gravity also influences the monthly cycles. “In the second halves of 1961, 1979, 1997, and 2015, the menstrual cycles of seven out of nine women were synchronous with the change of full moon and new moon,” says Charlotte Förster. This interval of 18 years corresponds exactly to the rhythm in which the three lunar cycles combine to produce very special constellations. This conjunction may have enhanced the moon’s strength as a clock generator. The observation that gravity sets a rhythm for humans could explain why certain cycles, such as menstruation but also sleep onset and sleep duration, are temporarily linked to either the full moon or the new moon: In both phases the influence of the moon’s gravity on Earth is similar. Effects of gravity could also explain a study’s observation that both sleep onset and sleep duration of college students are in sync with the lunar cycle — even though they live in Seattle, a city that is so bright at night that moonlight is barely perceptible. For Förster and her colleagues, all these observations suggest that the human organism can respond not only to rapid changes in gravity, as perceived by the equilibrium system, but also to slow, periodically recurring gravitational changes. However, the scientists are aware of the limited significance of their study due to the relatively small number of women studied. Her hopes are therefore pinned on the use of technology that is both simple and modern: a mobile phone app. This will make it possible to study the relationship between menstrual and lunar cycles and the influence of artificial light on a large number of women around the world. Reference: “Women temporarily synchronize their menstrual cycles with the luminance and gravimetric cycles of the Moon” by C. Helfrich-Förster, S. Monecke, I. Spiousas, T. Hovestadt, O. Mitesser and T. A. Wehr, 27 January 2021, Science Advances. DOI: 10.1126/sciadv.abe1358
A previously unknown stem cell, DDR2+, is linked to craniosynostosis, a condition causing infants’ skulls to fuse prematurely, according to Weill Cornell Medicine research. This discovery may lead to new treatments. This conceptual rendering shows how a new stem cell in the joints between the flat bones of the skull drives skull growth and fusion. Credit: Greenblatt lab, AI image generated using Midjourney Researchers at Weill Cornell Medicine have found that the premature fusion of the skull in infants, known as craniosynostosis, is caused by an increase in a previously unidentified stem cell, the DDR2+ stem cell. This discovery offers potential for treatments beyond surgery. Craniosynostosis, the premature fusion of the top of the skull in infants, is caused by an abnormal excess of a previously unknown type of bone-forming stem cell, according to a preclinical study led by researchers at Weill Cornell Medicine. Craniosynostosis arises from one of several possible gene mutations, and occurs in about one in 2,500 babies. By constricting brain growth, it can lead to abnormal brain development if not corrected surgically. In complex cases, multiple surgeries are needed. Research Findings In the study, which was recently published in the journal Nature, the researchers examined in detail what happens in the skull of mice with one of the most common mutations found in human craniosynostosis. They found that the mutation drives premature skull fusion by inducing the abnormal proliferation of a type of bone-making stem cell—the DDR2+ stem cell—that had never been described before. A new stem cell driving disorders of premature skull fusion was transplanted (red), showing that it makes the cartilage seen at sites of skull fusion (green). Credit: Greenblatt lab “We can now start to think about treating craniosynostosis not just with surgery but also by blocking this abnormal stem cell activity,” said study co-senior author Dr. Matt Greenblatt, an associate professor of pathology and laboratory medicine at Weill Cornell Medicine and a pathologist at NewYork-Presbyterian/Weill Cornell Medical Center. The other co-senior author of the study was Dr. Shawon Debnath, a research associate in the Greenblatt laboratory. In a study published in Nature in 2018, Drs. Debnath and Greenblatt and their colleagues described the discovery of a type of bone-forming stem cell they called the CTSK+ stem cell. Because this type of cell is present in the top of the skull, or “calvarium,” in mice, they suspected that it has a role in causing craniosynostosis. Unforeseen Results and Future Implications In the new study, they investigated that possibility by engineering mice in which CTSK+ stem cells lack one of the genes whose loss of function causes craniosynostosis. They expected that the gene deletion somehow would induce these calvarial stem cells to go into bone-making overdrive. This new bone would fuse the flexible, fibrous material called sutures in the skull that normally allow it to expand in infants. “We were surprised to find that, instead of the mutation in CTSK+ stem cells leading to these stem cells being activated to fuse the bony plates in the skull as we expected, mutations in the CTSK+ stem cells instead led to the depletion of these stem cells at the sutures—and the greater the depletion, the more complete the fusion of the sutures,” Dr. Debnath said. The unexpected finding led the team to hypothesize that another type of bone-forming stem cell was driving the abnormal suture fusion. After further experiments, and a detailed analysis of the cells present at fusing sutures, they identified the culprit: the DDR2+ stem cell, whose daughter cells make bone using a different process than that utilized by CTSK+ cells. The team found that CTSK+ stem cells normally suppress the production of the DDR2+ stem cells. However, the craniosynostosis gene mutation causes the CTSK+ stem cells to die off, allowing the DDR2+ cells to proliferate abnormally. To investigate these stem cells in human tissue, the team formed a collaboration with craniosynostosis surgeon Dr. Caitlin Hoffman, neurogeneticist Dr. Elizabeth Ross, and neuropathologist Dr. David Pisapia, all at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center; and craniosynostosis surgeon Dr. Thomas Imahiyerobo of Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian/Columbia University Irving Medical Center. The researchers found the human versions of DDR2+ stem cells and CTSK+ stem cells in calvarial samples from craniosynostosis surgeries—underscoring the likely clinical relevance of their findings in mice. The findings suggest that inappropriate DDR2+ stem cell proliferation in the calvarium, in infants with craniosynostosis-linked gene mutations, could be treated by suppressing this stem cell population, through mimicking the methods that CTSK+ stem cells normally use to prevent expansion of DDR2+stem cells. The researchers found that the CTSK+ stem cells achieve this suppression by secreting a growth factor protein called IGF-1, and possibly other regulatory proteins. “We observed that we could partly prevent calvarial fusion by injecting IGF-1 over the calvarium,” said study first author Dr. Seoyeon Bok, a postdoctoral researcher in the Greenblatt laboratory. “I can imagine DDR2+ stem cell-suppressing drug treatments being used along with surgical management, essentially to limit the number of surgeries needed or enhance outcomes,” Dr. Greenblatt said. In addition to treatment-oriented research, he and his colleagues now are looking for other bone-forming stem cell populations in the skull. “This work has uncovered much more complexity in the skull than we ever imagined, and we suspect the complexity doesn’t end with these two stem cell types,” Dr. Greenblatt said. Reference: “A multi-stem cell basis for craniosynostosis and calvarial mineralization” by Seoyeon Bok, Alisha R. Yallowitz, Jun Sun, Jason McCormick, Michelle Cung, Lingling Hu, Sarfaraz Lalani, Zan Li, Branden R. Sosa, Tomas Baumgartner, Paul Byrne, Tuo Zhang, Kyle W. Morse, Fatma F. Mohamed, Chunxi Ge, Renny T. Franceschi, Randy T. Cowling, Barry H. Greenberg, David J. Pisapia, Thomas A. Imahiyerobo, Shenela Lakhani, M. Elizabeth Ross, Caitlin E. Hoffman, Shawon Debnath and Matthew B. Greenblatt, 20 September 2023, Nature. DOI: 10.1038/s41586-023-06526-2
DVDV1551RTWW78V
One-stop OEM/ODM solution provider Vietnam 》minimizing lead time, maximizing product valueTaiwan athletic insole OEM production plant 》built to serve both niche and mass production needsIndonesia OEM insole and pillow supplier 》the ideal partner for high-performance, eco-friendly product lines